Abzena plots 6th biologics plant as demand for mammalian cell-line production continues to grow
With demand for biologics manufacturing at an all-time high, UK CDMO Abzena has rushed to add a bigger footprint to keep up. Now looking to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
